Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986-2009);Factores sociodemográficos asociados a la progresión de la infección por VIH e impacto del TARGA en una cohorte de pacientes seroconvertores en Madrid (1986-2009)

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 3, 2012, Pages 117-123

  Monge, Susana ^a   Del Romero, Jorge ^b   Rodríguez, Carmen ^b   De Mendoza, Carmen ^c   De Górgolas, Miguel ^d   Cosín, Jaime ^e   Dronda, Fernando ^f   Pérez Cecilia, Elisa ^g   Peña, José María ^c   Santos, Ignacio ^h   Rubio, Rafael ⁱ   Del Amo, Julia ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Disease progression; Educational level; HIV AIDS; Seroconverters; Socio economic factors

Indexed keywords

ARTICLE; DEMOGRAPHY; DISEASE COURSE; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; SEROCONVERSION; SPAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE FACTORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; MODELS, THEORETICAL; PROSPECTIVE STUDIES; RISK; SOCIOECONOMIC FACTORS; SPAIN; YOUNG ADULT;

EID: 84857791248     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.07.016     Document Type: Article

References (30)

1. J. Castilla Epidemiología de la infección por VIH/SIDA en España J. Del Amo, M.J. Belza, S. Castillo, A. Llacer, Prevención del VIH/SIDA en inmigrantes y minorías étnicas 2001 MSC Madrid 35 38
2. Servicio de Epidemiología de la CAM. Boletín epidemiológico de la Comunidad de Madrid: Vigilancia de la infección por VIH/sida, 2008.
3. P.M. Tarwater, J. Mellors, M.E. Gore, J.B. Margolick, J. Phair, and R. Detels Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts Am J Epidemiol 154 2001 675 681 (Pubitemid 32888786)
4. CASCADE Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE AIDS 14 2000 1899 1906
5. J. Del Amo, J. Del Romero, A. Barrasa, S. Perez-Hoyos, C. Rodriguez, and M. Diez Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999 Sex Transm Infect 78 2002 255 260
6. I. Jarrin, R. Geskus, S. Perez-Hoyos, and J. Del Amo Principales métodos de análisis en los estudios de cohortes de sujetos diagnosticados de infección por el virus de la inmunodeficiencia humana (VIH) Enferm Infecc Microbiol Clin 28 2010 298 303
7. I. Jarrin, F. Bolumar, and J. Del Amo Los estudios de cohortes y su contribución al conocimiento de la progresión de la infección por el virus de la inmunodeficiencia humana (VIH): Principales características y limitaciones Enferm Infecc Microbiol Clin 28 2010 304 309
8. S.G. Davey, C. Hart, D. Hole, P. MacKinnon, C. Gillis, and G. Watt Education and occupational social class: which is the more important indicator of mortality risk? J Epidemiol Community Health 52 1998 153 160 (Pubitemid 28130169)
9. N. Krieger, D.R. Williams, and N.E. Moss Measuring social class in US public health research: concepts, methodologies, and guidelines Annu Rev Public Health 18 1997 341 378 (Pubitemid 27194075)
10. V. Skalicka, L.F. van, C. Bambra, S. Krokstad, and J. Mackenbach Material, psychosocial, behavioural and biomedical factors in the explanation of relative socio-economic inequalities in mortality: evidence from the HUNT study Int J Epidemiol 38 2009 1272 1284
11. C. Junghans, N. Low, P. Chan, A. Witschi, P. Vernazza, and M. Egger Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study AIDS 13 1999 2547 2554 (Pubitemid 30038033)
12. M.T. Schechter, R.S. Hogg, B. Aylward, K.J. Craib, T.N. Le, and J.S. Montaner Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care J Clin Epidemiol 47 1994 59 67 (Pubitemid 24034291)
13. I. Jarrin, B. Lumbreras, I. Ferreros, S. Perez-Hoyos, I. Hurtado, and I. Hernandez-Aguado Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART Int J Epidemiol 36 2007 187 194 (Pubitemid 47061596)
14. M. Mari-Dell'olmo, M. Rodriguez-Sanz, P. Garcia-Olalla, M.I. Pasarin, M.T. Brugal, and J.A. Cayla Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe J Epidemiol Community Health 61 2007 232 240 (Pubitemid 46579559)
15. W. McFarland, S. Chen, L. Hsu, S. Schwarcz, and M. Katz Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco J Acquir Immune Defic Syndr 33 2003 96 103 (Pubitemid 36547247)
16. E. Rapiti, D. Porta, F. Forastiere, D. Fusco, and C.A. Perucci Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group Epidemiology 11 2000 496 501 (Pubitemid 30660026)
17. C. Borrell, M. Rodriguez-Sanz, M.I. Pasarin, M.T. Brugal, P. Garcia-de-Olalla, and M. Mari-Dell'olmo AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System? Eur J Public Health 16 2006 601 608 (Pubitemid 44899961)
18. E. Wood, J.S. Montaner, K. Chan, M.W. Tyndall, M.T. Schechter, and D. Bangsberg Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996 AIDS 16 2002 2065 2072 (Pubitemid 35205271)
19. Efecto del nivel educativo en la progresión de la infección por VIH en sujetos seroconvertores. Comunicación Oral. XVIII Reunión Científica de la Sociedad Española de Epidemiología; Valencia, Octubre 2010.
20. J. Collazos, V. Asensi, J.A. Carton, and S. Ibarra The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints AIDS Care 21 2009 511 519
21. E. Zaragoza-Macias, D. Cosco, M.L. Nguyen, C. Del Rio, and J. Lennox Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population AIDS Res Hum Retroviruses 26 2010 133 138
22. E. Regidor, S. De Mateo, M.E. Calle, and V. Domínguez Educational level and mortality from infectious diseases J Epidemiol Community Health 56 2002 682 683
23. P. Pezzotti, A.N. Phillips, M. Dorrucci, A.C. Lepri, N. Galai, and D. Vlahov Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversión. HIV Italian Seroconversion Study Group BMJ 313 1996 583 586 (Pubitemid 26293641)
24. K. Porter, A. Babiker, K. Bhaskaran, J. Darbyshire, P. Pezzotti, and K. Porter Determinants of survival following HIV-1 seroconversion after the introduction of HAART Lancet 362 2003 1267 1274 (Pubitemid 37324254)
25. A. Alioum, V. Leroy, D. Commenges, F. Dabis, and R. Salamon Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine Epidemiology 9 1998 605 612 (Pubitemid 28476119)
26. CASCADE Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe Lancet 355 2000 1131 1137
27. F. Belanger, L. Meyer, N. Carre, A. Coutellier, and C. Deveau Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: the SEROCO cohort (1988-1994). The Seroco Study Group Int J Epidemiol 26 1997 1340 1345 (Pubitemid 28010453)
28. C.A. Sabin, C.J. Smith, A. d'Arminio Monforte, M. Battegay, C. Gabiano, and L. Galli Response to combination antiretroviral therapy: variation by age AIDS 22 2008 1463 1473
29. T.E. Yamashita, J.P. Phair, A. Munoz, J.B. Margolick, R. Detels, and S.J. O'Brien Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study AIDS 15 2001 735 746 (Pubitemid 32423221)
30. A.H. Greenbaum, L.E. Wilson, J.C. Keruly, R.D. Moore, and K.A. Gebo Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals AIDS 22 2008 2331 2339